Company Overview

Company name: Nuuvera
Description: Producer of medicinal marijuana products. The company is engaged in the testing, formulation, production, extraction and sale of medicinal cannabis products in Canada and other legal International jurisdictions through its subsidiaries.
Year founded: 2015
Parent company: Aphria
Industry: Healthcare | Group: Pharmaceuticals and Biotechnology | Code:
Employees: 35
City: Leamington
State: Ontario
Country: Canada
Region: Americas

Financial Highlights

Start up capital raised (USD Million): 19.49
Business status: Generating Revenue
Ownership: Acquired/Merged (Operating Subsidiary)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period:
Financing Status: The company (TSX: NUU) was acquired by Aphria (TSX: APH) for $826 million on March 23, 2018. Nuuvera also announced to increase the size of its previously announced CAD 35 million bought deal offering led by Clarus Securities and Canaccord Genuity on January 18, 2018. Delavaco Group is the special adviser to Nuuvera on the bought deal offering. Nuuvera shareholders will receive 0.3546 common shares of Aphria, plus CAD 0.60 in cash for each Nuuvera share held, representing an aggregate implied transaction value of approximately CAD 826 million.
Number of active investors:
Profile last updated: 08-Sep-2018
Last known valuation: 826.00
Last known valuation date: 23-Mar-2018